Skip to main content
OpenTrials
Completed

NCT Number: NCT01024868

Assessment of Spread of Transversus Abdominis Plane Block

For the purpose of assessing the spread of the local anaesthetic after injecting it between abdominal muscles on both sides, the investigators will test if the patient can feel a change in the perception of cold and warm, as well as being pricked with a blunt needle. The investigators will also take several blood samples, together with routine samples, to measure the concentration of the local anesthetic in the blood.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Herlev University Hospital

Herlev, 2730, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • undergo abdominal surgery, eligible for TAP block, over 18, BMI 20-40

Exclusion criteria

  • does not speak danish, does not consent, does not fulfill inclusion criteria

Treatment and study plan

Ropivacaine 0,5%

Drug

Injection of ropivacaine 0,5% 20 ml bilaterally before surgery

Sponsors and collaborators

Lead sponsor

Herlev Hospital

Other

Collaborators

  • Glostrup University Hospital, Copenhagen

Registry information

Official study title

Assessment of Spread of Transversus Abdominis Plane Block After Administration of 20 ml Ropivacaine 0,5% Bilaterally

Important dates

Study start
2009
Primary completion
2010
First posted
Dec 3, 2009
Registry last updated
May 4, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.